CY1655A - Antiviral composition comprising isopropyldeoxyuridine - Google Patents

Antiviral composition comprising isopropyldeoxyuridine

Info

Publication number
CY1655A
CY1655A CY1655A CY165593A CY1655A CY 1655 A CY1655 A CY 1655A CY 1655 A CY1655 A CY 1655A CY 165593 A CY165593 A CY 165593A CY 1655 A CY1655 A CY 1655A
Authority
CY
Cyprus
Prior art keywords
isopropyldeoxyuridine
antiviral composition
antiviral
composition
Prior art date
Application number
CY1655A
Other languages
English (en)
Original Assignee
Mta Kozponti Kemial Kutato
Biogal Gyogyszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mta Kozponti Kemial Kutato, Biogal Gyogyszergyar filed Critical Mta Kozponti Kemial Kutato
Publication of CY1655A publication Critical patent/CY1655A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CY1655A 1987-08-07 1993-05-14 Antiviral composition comprising isopropyldeoxyuridine CY1655A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU873596A HU196038B (en) 1987-08-07 1987-08-07 Process for producing antiherpetic pharmaceutics for external use, containing 5-isopropyl-2'-beta-deoxy-uridine

Publications (1)

Publication Number Publication Date
CY1655A true CY1655A (en) 1993-05-14

Family

ID=10964716

Family Applications (1)

Application Number Title Priority Date Filing Date
CY1655A CY1655A (en) 1987-08-07 1993-05-14 Antiviral composition comprising isopropyldeoxyuridine

Country Status (25)

Country Link
US (2) US4880785A (ja)
JP (1) JPS6442437A (ja)
KR (1) KR960015953B1 (ja)
CN (1) CN1034133A (ja)
AU (1) AU605875B2 (ja)
BE (1) BE1001774A4 (ja)
CA (1) CA1286227C (ja)
CH (1) CH675538A5 (ja)
CS (1) CS276467B6 (ja)
CY (1) CY1655A (ja)
DD (1) DD270656A5 (ja)
DE (1) DE3820270A1 (ja)
DK (1) DK299088A (ja)
ES (1) ES2010559A6 (ja)
FI (1) FI883692A (ja)
FR (1) FR2619010B1 (ja)
GB (1) GB2207864B (ja)
GR (1) GR1000139B (ja)
HU (1) HU196038B (ja)
IT (1) IT1217789B (ja)
NL (1) NL8801411A (ja)
NO (1) NO882491L (ja)
RU (1) RU2035180C1 (ja)
SE (1) SE503261C2 (ja)
SG (1) SG42292G (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
HUP9602024A3 (en) * 1996-07-25 1999-05-28 Toth Sandor Pharmaceutical composition containing aminoacid for external use
MY136633A (en) * 2001-01-17 2008-11-28 Berlin Chemie Ag Stabilized brivudine topical formulations

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2918260A1 (de) * 1979-05-07 1980-11-27 Robugen Gmbh Anwendung von 5-alkyl-2'-desoxyuridinen
DE3010397A1 (de) * 1980-03-18 1981-10-29 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen Verwendung von 5-alkyl-pyrimidinnukleosiden als cytostatika
EP0085084A1 (de) * 1981-08-04 1983-08-10 Robugen Gmbh Pharmazeutische Fabrik Kombinationspräparat mit synergistischer wirkung
HU198393B (en) * 1984-03-06 1989-10-30 Sloan Kettering Inst Cancer Process for production of medical composition suitable for treatment of hepatitis containing as active substance derivatives of piramidin-nucleoside
HU197837B (en) * 1984-12-29 1989-06-28 Mta Koezponti Kemiai Kutato In Composition with skin cleaning effect, particularly for treating pimpled skin of face

Also Published As

Publication number Publication date
IT8820871A0 (it) 1988-06-06
FR2619010B1 (fr) 1992-02-14
CH675538A5 (ja) 1990-10-15
FR2619010A1 (fr) 1989-02-10
FI883692A (fi) 1989-02-08
GR880100417A (en) 1989-05-25
KR890003380A (ko) 1989-04-14
AU1741388A (en) 1989-02-09
CA1286227C (en) 1991-07-16
US4880785A (en) 1989-11-14
DK299088D0 (da) 1988-06-02
CN1034133A (zh) 1989-07-26
SG42292G (en) 1992-09-04
FI883692A0 (fi) 1988-08-08
AU605875B2 (en) 1991-01-24
SE8802193D0 (sv) 1988-06-13
IT1217789B (it) 1990-03-30
JPH0515694B2 (ja) 1993-03-02
GB2207864B (en) 1992-01-15
NO882491D0 (no) 1988-06-06
JPS6442437A (en) 1989-02-14
GR1000139B (el) 1991-09-27
DK299088A (da) 1989-02-08
ES2010559A6 (es) 1989-11-16
NO882491L (no) 1989-02-08
BE1001774A4 (fr) 1990-03-06
US4937233A (en) 1990-06-26
SE8802193L (sv) 1989-02-08
DD270656A5 (de) 1989-08-09
SE503261C2 (sv) 1996-04-29
GB2207864A (en) 1989-02-15
CS276467B6 (en) 1992-06-17
GB8813392D0 (en) 1988-07-13
DE3820270A1 (de) 1989-02-16
KR960015953B1 (ko) 1996-11-25
CS441388A3 (en) 1992-01-15
NL8801411A (nl) 1989-03-01
HU196038B (en) 1988-09-28
RU2035180C1 (ru) 1995-05-20

Similar Documents

Publication Publication Date Title
EP0293885A3 (en) Antibiotic-polymer compositions
GB8721936D0 (en) Composition
ZA88637B (en) Fire-resitant composition
EP0292963A3 (en) Fiber-treatment composition
GB2203336B (en) Composition
HUT51856A (en) Mollusquicid composition
GB8715191D0 (en) Composition
GB8821380D0 (en) Antiviral agents
EG18594A (en) Shampo composition
GB8702613D0 (en) Compositions
JPS6445371A (en) Antiviral compound
EP0243192A3 (en) Antiviral 8-phenylxanthines
GB2207864B (en) Antiviral composition comprising isopropyldeoxyuridine
JPS6471883A (en) Antiviral
GB8716338D0 (en) Anti-anxiogenic compositions
GB8826371D0 (en) Antiviral compositions
JPS6460631A (en) Polyfluoroalkoxyphosphazene composition
GB8700466D0 (en) Teat-treating compositions
GB8728869D0 (en) Antiviral agent
ZA886461B (en) Antiviral agent
GB8700495D0 (en) Antiviral compounds
PL268805A1 (en) Bituminuous composition
GB8702612D0 (en) Composition
GB8718669D0 (en) Composition
GB8718278D0 (en) Composition